{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-255973","form_type":"8-K","ticker":"BTMD","cik":"0001819253","company_name":"biote Corp.","filed_at":"2024-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.812855+00:00","generated_at":"2026-05-30T02:09:10.703748+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Biote Q3 revenue $51.4M (+12.8% YoY); EPS $0.33; Adj. EBITDA $16.2M","bullets":["Revenue of $51.4M, up 12.8% YoY; procedure revenue $37.9M.","Gross profit margin 70.5%, up from 64.5% a year ago on vertical integration savings.","Net income $12.7M ($0.33 diluted EPS) vs. $19.6M ($0.24) in Q3 2023.","Adjusted EBITDA $16.2M, margin 31.5%; grew 15.4% YoY.","Launched proprietary clinical decision support software in September 2024 to strengthen competitive position."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-255973","json":"https://secwatch.observer/filing/0001193125-24-255973.json","markdown":"https://secwatch.observer/filing/0001193125-24-255973.md","text":"https://secwatch.observer/filing/0001193125-24-255973.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819253/000119312524255973/0001193125-24-255973-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819253/000119312524255973/d880680d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T02:09:10.703748+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}